Ultragenyx Pharmaceutical
RARE
RARE
161 hedge funds and large institutions have $2.35B invested in Ultragenyx Pharmaceutical in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 53 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
-10
Holders Change %
-5.85%
% of All Funds
4.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
71
Reduced
53
Closed
30
Calls
$9.27M
Puts
$10.5M
Net Calls
-$1.28M
Net Calls Change
+$1.33M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$262M |
| 2 |
State Street
Boston,
Massachusetts
|
$81.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$24.1M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
$30.6M |
| 5 |
O
OrbiMed
New York
|
$8.12M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$13.3M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
$21.6M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
$1.25M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
$838K |
| 5 |
Jennison Associates
New York
|
$37M |
